NCT02079792View on ClinicalTrials.gov

The Optimal Head Position for Distributing Topical Nasal Medication Using the Mucosal Atomization Device

PHASE4CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

August 31, 2015

Conditions
Sinusitis
Interventions
PROCEDURE

Lying Head Back Position

Subjects randomized to the LHB position will be instructed to lay supine on the clinical table, with their head hanging over the edge of the bed as far as possible without discomfort.

PROCEDURE

Head Down and Forward Position

Subjects randomized to the HDF position will be instructed to kneel down, placing the top of their head on the ground and forehead close to the knees with the nostrils facing upwards.

Trial Locations (1)

V6Z 1Y6

St. Paul's Hospital Sinus Centre, Vancouver

All Listed Sponsors
lead

St. Paul's Hospital, Canada

OTHER

NCT02079792 - The Optimal Head Position for Distributing Topical Nasal Medication Using the Mucosal Atomization Device | Biotech Hunter | Biotech Hunter